About Johns Hopkins

Recent news from The Johns Hopkins University

This section contains regularly updated highlights of the news from around The Johns Hopkins University. Links to the complete news reports from the nine schools, the Applied Physics Laboratory and other centers and institutes are to the left, as are links to help news media contact the Johns Hopkins communications offices.

 

Johns Hopkins Experts Available to Discuss CDC, FDA Suspension of Johnson & Johnson Vaccine

Federal health agencies have asked for a temporary distribution suspension of the Johnson & Johnson vaccine after instances of blood clots linked to the shots. The decision is expected to halt or limit U.S. rollout of the vaccine, and Johns Hopkins University experts can offer perspective and commentary on the news.

Johns Hopkins Expert Available to Discuss Johnson & Johnson Vaccine Factory Error

A Johns Hopkins University health care expert is available to offer perspective on the news that a mistake at a Johnson & Johnson factory producing the COVID-19 vaccine resulted in the loss of millions of doses.

Johns Hopkins Carey Business School Presents Symposium on Health Care Industry Standards

The Johns Hopkins Carey Business School, in conjunction with the Food and Drug Law Institute, will hold a symposium, “Issues in Global Health: Advancing Efficiency and Quality through Regulatory Science,” from 7:45 a.m. to 3 p.m. on Dec. 2, 2011, at the National Press Club in Washington, D.C. Funding is provided by Johnson & Johnson. Carey professors Toby Gordon and Dipankar Chakravarti are co-conveners of the event.